Kolexia
Sigaud Marianne Biologie médicale
Sigaud Marianne
Biologie médicale
Hôpital Hôtel-Dieu Nantes
Nantes, France
66 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Maladies de von Willebrand Hémorragie Syndrome de Bernard-Soulier Hématurie Athérosclérose Paraprotéinémies Thrombopénie Fibrillation auriculaire

Collaborateurs

Voir plus
Fouassier Marc
Fouassier Marc
Hôpital Hôtel-Dieu Nantes, Nantes, France
Trossaert Marc
Trossaert Marc
Hôpital Hôtel-Dieu Nantes, Nantes, France
Ternisien Catherine
Ternisien Catherine
Hôpital Hôtel-Dieu Nantes, Nantes, France
Guillet Benoit
Guillet Benoit
Hôpital Pontchaillou, Rennes, France

Industries

Voir plus
Takeda Pharmaceutical
6 collaboration(s)
Dernière en 2021
Roche
4 collaboration(s)
Dernière en 2021
Sobi
4 collaboration(s)
Dernière en 2022
Bayer
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort.
Clinical drug investigation   30 novembre 2023
Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders.
European journal of haematology   08 août 2023
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.
European journal of haematology   13 juillet 2023
Reinvestigation of unidentified causative variants in FXI-deficient patients: Focus on gene segment deletions.
Haemophilia : the official journal of the World Federation of Hemophilia   04 octobre 2022
Biological, clinical features and modelling of heterozygous variants of glycoprotein Ib platelet subunit alpha (GP1BA) and glycoprotein Ib platelet subunit beta (GP1BB) genes responsible for constitutional thrombocytopenia.
British journal of haematology   29 septembre 2022
Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation.
Hamostaseologie   30 juin 2022
Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres.
Haemophilia : the official journal of the World Federation of Hemophilia   24 février 2022
PO051 EFFICACY AND SAFETY OF TUROCTOCOG ALFA IN PATIENTS WITH HAEMOPHILIA A REQUIRING SURGICAL PROCEDURES: A FRENCH SINGLE CENTRE RETROSPECTIVE STUDY
15th Annual Congress of European Association for Haemophilia and Allied Disorders 2022, 2–4 February 2022, Virtual Meeting   31 janvier 2022
Real-world Use of FVIII in People with Severe Hemophilia A without Inhibitor on Prophylaxis, Comparing Switched to rFVIII-Fc versus Non-switched Patients: A Multicentre, Retrospective, Non Interventional, before-after Study with the French Nationwide Claims Database (MOTHIF-II)
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Real-world Annual Bleeding Rate in People with Severe Hemophilia A without Inhibitor on Prophylaxis, Comparing Switched to rFVIII-Fc versus Non-switched Patients: A Multicentre, Retrospective, Non interventional, before-after Study with the French BERHLINGO Database (MOTHIF-II)
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021